Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Senex Biotechnology in June, 2020 for $1,130,935.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA203184-02A1 | Phase II | 1,130,935 | June 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Senex Biotechnology in September, 2022 for $400,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA271996-01A1 | Phase I | 400,000 | September 12, 2022 | |||||||
A SBIR Phase I contract was awarded to Senex Biotechnology in September, 2015 for $240,750.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA203184-01 | Phase I | 240,750 | September 23, 2015 | |||||||
A SBIR Phase I contract was awarded to Senex Biotechnology in September, 2017 for $299,151.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL137525-01 | Phase I | 299,151 | September 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Senex Biotechnology in July, 2017 for $299,993.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA221485-01 | Phase I | 299,993 | July 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Senex Biotechnology in December, 2016 for $299,891.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA213629-01 | Phase I | 299,891 | December 29, 2016 | |||||||
A SBIR Phase I contract was awarded to Senex Biotechnology for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG029023-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Senex Biotechnology for $107,001.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM081968-01A1 | Phase I | 107,001 | ||||||||
A SBIR Phase II contract was awarded to Senex Biotechnology for $1,548,102.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA141845-02 | Phase II | 1,548,102 | ||||||||
A SBIR Phase II contract was awarded to Senex Biotechnology for $802,501.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44CA139991-02A1 | Phase II | 802,501 | ||||||||
A SBIR Phase I contract was awarded to Senex Biotechnology for $107,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA141845-01 | Phase I | 107,000 |